Jia Lin, MD, PhD
- Call 216.444.4613
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Jia Lin, MD, PhD
Jia Wang Lin, MD, PhD, is a Staff Member of the Department of Cardiothoracic & Vascular Anesthesia. Her specialty interests include anesthesia for complicated cardiovascular and anesthesia for patients with difficult airways.
Dr. Lin earned her medical degree from Beijing Medical University Faculty of Medicine in Beijing, China. She earned her doctoral degree from the University of Texas Medical Branch in Galveston, Texas. She completed an internship at Beijing Medical University, a residency in anesthesiology and fellowship in cardiothoracic anesthesiology at the Cleveland Clinic in Cleveland, Oh.
She is certified by the American Board of Anesthesiology and the National Board of Echocardiography for Perioperative Transesophageal Echocardiography.
She is a member of the American Society for Anesthesiologists, the Society for Neuroscience, the International Anesthesia Research Society, Society of Cardiovascular Anesthesiologists and the Society for Airway Management.
Dr. Lin has published a number of peer-reviewed articles on various aspects of anesthesiology, neurosurgical anesthesia and pharmacology.
Education & Professional Highlights
Appointed
2001
Education & Fellowships
Fellowship - Cleveland Clinic
Cardiothoracic Anesthesiology
Cleveland,
OH
2003
Residency - Cleveland Clinic
Anesthesiology
Cleveland,
OH
2001
Medical Education - Beijing Medical University Faculty of Medicine
Beijing,
China
1995
Graduate School - University of Texas Medical School at Galveston
Galveston,
TX USA
1994
Undergraduate - Beijing Medical University Faculty of Medicine
Beijing,
1989
Certifications
- Anesthesiology
- Advanced Perioperative Transesophageal Echocardiography
Specialty Interests
Anesthesia for complicated cardiovascular surgery, anesthesia for endotracheal and bronchial surgery, anesthesia for interventional pulmonology procedures, anesthesia for vascular surgery, anesthesia for patients with difficult airways, anesthesia for transplant procedures, anesthesia recovery, brain protection, cardiothoracic anesthesia, intraoperative TEE, jet ventilation, perioperative anesthesia evaluation
Awards & Honors
- Global Directory of Who’s Who, honored member, 2007
- Best of Section: “Airway Management in a 980 Pound Patient: Lessons Learned,” IARS 80th Clinical and Scientific Congress, Challenging Clinical Cases, San Francisco, Calif., 2006
- Second Place, Clinical Science/CV, Midwest Anesthesiology Residents Conference Meeting, Abstracts, Rochester, Minn., 2004
- First Place, Best Poster Award, Annual Poster Session of the Galveston Chapter, Society for Neuroscience, Galveston, Texas, 1991
Research & Publications
See publications for Jia Lin, MD, PhD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 7/3/2023, Dr. Lin has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
